Inhibition of EHMT1 and EHMT2 with BIX01294 enhances the cytotoxicity of IFNα2a in four CML cell lines, K562, KCL22, BV173 and KT1 cells. The gene discussed is IFNA2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.